If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Software Group Regulatory News (APTD)

Share Price Information for Aptitude Software Group (APTD)

Share Price is delayed by 15 minutes
Get Live Data
204.00    6.00 (3.03%)
Bid:
201.00
Ask:
204.00
Spread: 3.00 (1.493%)
Market Cap: £109.18m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Software Group Share Chart

Interim Management Statement and Special Dividend

1 Nov 2011 07:00

RNS Number : 2017R
Microgen PLC
01 November 2011
 



microgen

www.microgen.com

 

1 November 2011

 

INTERIM MANAGEMENT STATEMENT AND SPECIAL DIVIDEND

 

Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 July 2011 to the date of this announcement. Microgen released its interim results for the six months ending 30 June 2011 on 21 July 2011.

 

There have been no significant changes since 1 July 2011 in the trading or financial position of Microgen and its balance sheet remains strong. In September, Microgen repaid the £1.6 million loan associated with its Fleet freehold property, after which the Group had cash at 30 September 2011 of £26.0 million (Net Funds at 30 June 2011 : £25.2 million).

 

Since 1 July 2011 the Microgen Aptitude Solutions Division ("MASD") has further expanded its customer base and the Financial Systems Division ("FSD") continues to perform satisfactorily in a flat market environment. Due in part to the consultancy demand on a number of projects in 2011, the Group's performance is now anticipated to be moderately ahead of the Board's expectations for the year, although the Board remains cautious due to the current macro-economic environment.

 

As a result of the strong financial position of Microgen, the Board has decided to pay a special dividend of 5.0 pence per share. The special dividend will be paid on 9 December 2011 to shareholders on the register as at 11 November 2011.

 

Three years ago, in October 2008, the Board introduced the Value Enhancement and Realisation Bonus Scheme ("VERBS"), at which time the market capitalisation of Microgen was £37.0 million. Including the forthcoming special dividend the Board has, since the introduction of VERBS, returned £28.2 million to shareholders through a progressive dividend policy, special dividends and tender offers. This is equivalent to over 75% of the Group's market capitalisation at the time of the introduction of VERBS. Furthermore, Microgen's market capitalisation, at 31 October 2011, has increased to £122.9 million.

 

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

David Sherriff, Chief Executive Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, FTI Consulting 020-7831-3113

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUAABRAOAROAA
Date   Source Headline
6th Jul 20207:21 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSTrading Update and Notice of Results
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20204:35 pmRNSPrice Monitoring Extension
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSTotal Voting Rights
29th Apr 202012:16 pmRNSDisclosure of Rights attached to Ordinary Shares
28th Apr 202012:45 pmRNSResult of AGM
21st Apr 20207:00 amRNSCOVID-19 Update and AGM Arrangements
8th Apr 20205:02 pmRNSDirector/PDMR Shareholding
8th Apr 20204:59 pmRNSDirector/PDMR Shareholding
27th Mar 202012:38 pmRNSBlock listing Interim Review
18th Mar 20205:00 pmRNSAnnual Report and Notice of AGM
16th Mar 20201:52 pmRNSBlock Listing Application
13th Mar 20205:11 pmRNSDirector/PDMR Shareholding
11th Mar 20207:00 amRNSAudited Preliminary Results
13th Feb 20205:26 pmRNSHolding(s) in Company
3rd Feb 20201:54 pmRNSTotal Voting Rights
22nd Jan 20202:44 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSTrading Update, Board Changes & Notice of Results
15th Jan 202012:01 pmRNSHolding(s) in Company
3rd Jan 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jan 202012:02 pmRNSPrice Monitoring Extension
3rd Jan 20207:00 amRNSTotal Voting Rights
3rd Dec 20192:52 pmRNSHolding(s) in Company
2nd Dec 201910:28 amRNSTotal Voting Rights
12th Nov 20191:48 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSHolding(s) in Company
1st Nov 20197:00 amRNSTotal Voting Rights
29th Oct 20197:00 amRNSAward of Options
23rd Oct 20193:19 pmRNSHolding(s) in Company
4th Oct 20197:00 amRNSChange of Auditor and Partner Programme
30th Sep 20196:03 pmRNSHolding(s) in Company
30th Sep 20197:21 amRNSHolding(s) in Company
27th Sep 20199:35 amRNSHolding(s) in Company
26th Sep 20192:25 pmRNSBlock Listing Interim Review
26th Sep 20198:30 amRNSAcceptance of the B Share Purchase Offer
25th Sep 20198:00 amRNSPurchase Offer for B Shares
24th Sep 20197:00 amRNSIssue of B Shares and Share Consolidation
23rd Sep 20191:50 pmRNSReturn of Value and Result of GM
11th Sep 20196:03 pmRNSHolding(s) in Company
9th Sep 20192:27 pmRNSHolding(s) in Company
9th Sep 20192:13 pmRNSHolding(s) in Company
3rd Sep 20197:00 amRNSPublication of Circular and Notice of GM
2nd Sep 20194:16 pmRNSCorrection: Issue of Consideration Shares
2nd Sep 20191:37 pmRNSConfirmation of Directorate Change
2nd Sep 20197:00 amRNSIssue of Consideration Shares
29th Aug 20191:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.